Loading...
MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7
Malignant gliomas are the most common tumor in central nervous system with poor prognosis. Due to the limitation of histological classification in earlier diagnosis and individualized medicine, it is necessary to combine the molecular signatures and the pathological characteristics of gliomas. Lots...
Saved in:
Published in: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Nature Publishing Group UK
2020
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7058039/ https://ncbi.nlm.nih.gov/pubmed/32139705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-60218-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|